Search Results

You are looking at 1 - 5 of 5 items for :

  • ciprofloxacin x
  • General Orthopaedics x
Clear All
Sylvain Steinmetz Service of Orthopaedics and Traumatology, Lausanne University Hospital, Lausanne, Switzerland

Search for other papers by Sylvain Steinmetz in
Google Scholar
PubMed
Close
,
Diane Wernly Service of Orthopaedics and Traumatology, Lausanne University Hospital, Lausanne, Switzerland

Search for other papers by Diane Wernly in
Google Scholar
PubMed
Close
,
Kevin Moerenhout Service of Orthopaedics and Traumatology, Lausanne University Hospital, Lausanne, Switzerland

Search for other papers by Kevin Moerenhout in
Google Scholar
PubMed
Close
,
Andrej Trampuz Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Center for Musculoskeletal Surgery (CMSC), Berlin, Germany

Search for other papers by Andrej Trampuz in
Google Scholar
PubMed
Close
, and
Olivier Borens Service of Orthopaedics and Traumatology, Lausanne University Hospital, Lausanne, Switzerland

Search for other papers by Olivier Borens in
Google Scholar
PubMed
Close

-negative Enterobacteriaceae (E. coli, Klebsiella, Enterobacter etc.) - Ciprofloxacin 750 mg, every 12 h p.o. Nonfermenteres (Pseudomonas aeruginosa, Acinetobacter spp.) 2–3 weeks:  - Piperacillin/tazobactam or  - Meropenem or  - Ceftazidim +  - Tobramycin or

Open access
T. Fintan Moriarty AO Research Institute Davos, Switzerland

Search for other papers by T. Fintan Moriarty in
Google Scholar
PubMed
Close
,
Richard Kuehl University Hospital of Basel, Switzerland

Search for other papers by Richard Kuehl in
Google Scholar
PubMed
Close
,
Tom Coenye Ghent University, Belgium

Search for other papers by Tom Coenye in
Google Scholar
PubMed
Close
,
Willem-Jan Metsemakers University Hospitals Leuven, Belgium

Search for other papers by Willem-Jan Metsemakers in
Google Scholar
PubMed
Close
,
Mario Morgenstern Trauma Centre, Murnau, Germany

Search for other papers by Mario Morgenstern in
Google Scholar
PubMed
Close
,
Edward M. Schwarz University of Rochester Medical Center, New York, USA

Search for other papers by Edward M. Schwarz in
Google Scholar
PubMed
Close
,
Martijn Riool AMC, University of Amsterdam, The Netherlands

Search for other papers by Martijn Riool in
Google Scholar
PubMed
Close
,
Sebastian A.J. Zaat AMC, University of Amsterdam, The Netherlands

Search for other papers by Sebastian A.J. Zaat in
Google Scholar
PubMed
Close
,
Nina Khana University Hospital of Basel, Switzerland

Search for other papers by Nina Khana in
Google Scholar
PubMed
Close
,
Stephen L. Kates Virginia Commonwealth University, Virginia, USA

Search for other papers by Stephen L. Kates in
Google Scholar
PubMed
Close
, and
R. Geoff Richards AO Research Institute Davos, Switzerland

Search for other papers by R. Geoff Richards in
Google Scholar
PubMed
Close

be challenging. 22 With reference to ODRI, bacteria resistant to the few antibiotics with proven anti-biofilm activity (Rifampicin-resistant staphylococci and ciprofloxacin-resistant Gram-negatives) are among the most difficult pathogens to treat

Open access
Christof Berberich Department of Medical Training and Education, Heraeus Medical GmbH, Wehrheim, Germany

Search for other papers by Christof Berberich in
Google Scholar
PubMed
Close
and
Pablo Sanz-Ruiz Department of Traumatology and Orthopaedic Surgery, General University Hospital Gregorio Marañón, Madrid, Spain

Search for other papers by Pablo Sanz-Ruiz in
Google Scholar
PubMed
Close

susceptibility to antibiotics used for treatment of PJI remained largely unchanged, including rifampicin, daptomycin and vancomycin against gram-positive bacteria or ciprofloxacin, meropenem and ceftazidime against gram-negative bacteria. Table 2. Number of

Open access
Petra Izakovicova HELIOS Klinik Zerbst/Anhalt, Germany

Search for other papers by Petra Izakovicova in
Google Scholar
PubMed
Close
,
Olivier Borens Service of Orthopaedics and Traumatology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland

Search for other papers by Olivier Borens in
Google Scholar
PubMed
Close
, and
Andrej Trampuz Charité – Universitätsmedizin Berlin, Corporate Member of Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Center for Musculoskeletal Surgery (CMSC), Berlin, Germany

Search for other papers by Andrej Trampuz in
Google Scholar
PubMed
Close

and ciprofloxacin . Antimicrob Agents Chemother 2003 ; 47 : 1251 – 1256 . 11. Gbejuade HO Lovering AM Webb JC . The role of microbial biofilms in prosthetic joint infections . Acta Orthop 2015 ; 86 : 147

Open access
Zaki Arshad University of Cambridge School of Clinical Medicine, Cambridge, UK

Search for other papers by Zaki Arshad in
Google Scholar
PubMed
Close
,
Edward Jun-Shing Lau University of Cambridge School of Clinical Medicine, Cambridge, UK

Search for other papers by Edward Jun-Shing Lau in
Google Scholar
PubMed
Close
,
Aiman Aslam University of Cambridge School of Clinical Medicine, Cambridge, UK

Search for other papers by Aiman Aslam in
Google Scholar
PubMed
Close
,
Azeem Thahir Department of Trauma and Orthopaedic Surgery, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Azeem Thahir in
Google Scholar
PubMed
Close
, and
Matija Krkovic Department of Trauma and Orthopaedic Surgery, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Matija Krkovic in
Google Scholar
PubMed
Close

fenestrated and necrotic bone sequestra excised. Suction drain placed in remaining gutter. Dead space obliterated with free muscle transfer. IV ciprofloxacin given at time of surgery and then orally for 6 weeks post-operatively. If microbiology culture and

Open access